Učitavanje...
Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial)
BACKGROUND: With the availability of infliximab, nowadays recurrent Crohn's disease, defined as disease refractory to immunomodulatory agents that has been treated with steroids, is generally treated with infliximab. Infliximab is an effective but expensive treatment and once started it is uncl...
Spremljeno u:
Glavni autori: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
BioMed Central
2008
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2533646/ https://ncbi.nlm.nih.gov/pubmed/18721465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2482-8-15 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|